A peptide encoded by the 3B region of the picornavirus genome termed VPg (
virion
protein
genome linked) is covalently linked to the 5′ end of all picornaviral RNAs (
1,
28). Production of VPg-linked RNA is catalyzed by the viral polymerase 3Dpol in a two-step reaction. VPg or some precursor thereof is used to produce VPg-pUpU; VPg-pUpU is then used as a primer for production of full-length positive- or negative-sense RNA. A
cis-acting replication element termed the “cre” or “oriI” is present at an internal position relative to the 5′ and 3′ ends of the picornaviral genome that is absolutely essential for genome replication (
7,
9,
12,
16). Because
cis-acting elements exist at the 5′ (oriL) and 3′ (oriR) ends of picornaviral genomes and the cre required for VPg is located at different positions in different PVs, herein we will use oriI to refer to the template for VPg uridylylation in order to preclude confusion as suggested by Paul (
23).
oriI is an RNA stem-loop that has been shown to serve as an efficient template for production of VPg-pUpU in a 3Dpol-catalyzed reaction that is greatly stimulated by viral protein 3C or 3CD (
22,
25,
27,
33). A single adenylate residue in the oriI loop serves as template for addition of both uridylate residues by using a slide-back mechanism similar to that observed in DNA phage phi29 (
26). It is important to note that evaluation of VPg uridylylation in a cell-free system has shown that the cloverleaf (oriL) located in the 5′ untranslated region of picornaviral RNAs is required for VPg uridylylation (
14). However, the function of the cloverleaf in VPg uridylylation is not clear (
14). The suggestion has been made that this structure may facilitate delivery and/or activation of viral factors required for uridylylation (
14). Consistent with this possibility is the fact that the use of processed proteins bypasses the dependence on the cloverleaf in vitro (
22).
Our current model for the assembly and organization of the picornavirus VPg uridylylation complex is shown in Fig.
1 (
21). This model is consistent with all of the currently available molecular genetic and biochemical studies performed to date in tissue culture, in cell-free systems, and in systems reconstituted from purified components (
7,
18,
19,
21,
22,
24,
27,
30-
33). A dimer of 3C(D) binds to oriI guided by an interaction between 3C and the upper stem of oriI. This complex isomerizes such that the upper stem opens to permit each of the single strands to interact with each 3C molecule. This isomerization is predicted to extend the loop into a conformation that will bind more readily to the RNA-binding site of 3Dpol (
21), as suggested by structural studies of oriI (
29). 3Dpol adds to this complex and is stabilized therein by an interaction between the back of the thumb of 3Dpol and a surface of the 3C dimer. VPg or some precursor thereof would either enter in association with 3Dpol (
21) or join after 3Dpol binding. Although the catalytic sites for VPg-primed and RNA-primed RNA synthesis are the same, structural (
6) and biochemical (
11) studies suggest that the specific molecular interaction of nucleotide substrate with the 3Dpol active site is dependent on the primer employed. The overall organization of all picornavirus VPg uridylylation complexes will likely be similar. However, as suggested by the model, determinants for assembly and stability of this complex can be distributed across many protein-protein and protein-RNA interfaces.
oriI elements from human rhinovirus type 14 (HRV-14), poliovirus type 1 (PV-1), and PV-3 are shown in Fig.
2A. A loop consensus sequence has been defined (
31). In contrast, a consensus sequence has not been defined for the stem, suggesting that only the structural stability of the stem is important for oriI function. Consistent with this possibility are two findings. First, a functional oriI has been created that contains a consensus loop in the context of a completely artificial stem (
10). Second, PV-1 oriI can be replaced by the oriI element from HRV-14 without significant impact on replication efficiency (
25). However, the observation that HRV-14 replication was impaired by using oriI from PV-3 suggested that protein factors might have undefined sequence-specific interactions with oriI (
32). Consistent with this possibility was the finding that mutations in 3C and 3D coding sequence of HRV-14 could increase the efficiency of replication of an HRV-14 genome containing oriI from PV-3 (
32). The mutation in 3C coding sequence changed Leu-94 to Pro; the mutation in 3D coding sequence changed Asp-406 to Asn. The mechanism(s) for adaptation is unknown.
MATERIALS AND METHODS
Materials.
Deep Vent DNA polymerase and restriction enzymes were from New England Biolabs, Inc.; shrimp alkaline phosphatase was from USB; T4 DNA ligase was from Invitrogen Life Technologies; Difco-NZCYM was from BD Biosciences; QIAEX beads were from QIAGEN; RNase A was from Sigma; Ultrapure UTP solution was from GE Healthcare; [α-32P]UTP (6,000 Ci/mmol) was from Perkin-Elmer Life Sciences, Inc.; synthetic PV and HRV-14 VPg peptides were purchased from Alpha Diagnostic International (San Antonio, TX); all other reagents and apparatuses were available through Fisher or VWR or as indicated.
Cloning and transcription of HRV-14, PV-3, and HRV-14/PV-3 chimeric oriIs.
Cloning and transcription of PV-1 61-nucleotide (nt) oriI were performed as described previously (
22). DNA fragments carrying HRV-14 97-nt oriI were generated by PCR amplification using oligonucleotides 12 and 13 (Table
1) and cloned into a pUC18 vector using BamHI and EcoRI sites. Transcription reactions were performed as described for PV 61-nt oriI (
22). The extinction coefficient for HRV-14 97-nt oriI was 1.1328 μM
−1·cm
−1. The plasmids ΔP1Luc-PV3 oriI, ΔP1Luc-PV lp, and ΔP1Luc-PV stem were constructed as described previously (
32). DNA fragments carrying PV-3 oriI, PV-3 stem (HRV-14 loop), and PV-3 lp (HRV-14 stem) were generated by PCR amplification with replicons of ΔP1Luc-PV3 oriI, ΔP1Luc-PV lp, or ΔP1Luc-PV stem as templates using oligonucleotides 14 and 15 and oligonucleotides 12 and 13 (Table
1). Transcription reactions were performed as described previously for PV 61-nt oriI (
22). The extinction coefficients for PV-3 oriI, PV-3 stem, and PV-3 lp were 0.7841, 0.7511, and 1.1613 μM
−1·cm
−1, respectively.
Construction of pET26Ub HRV-14 3D WT and 3D D406N.
For 3D wild type (WT), a PCR fragment was made with HRV-14 viral cDNA (
15) as a template using oligonucleotides 7 and 8 as primers (Table
1). For 3D D406N, first two PCR fragments were amplified using oligonucleotides 7 and 8 and oligonucleotides 10 and 11 (Table
1) encoding point mutation D406N. These two fragments were then used as templates for the amplification of a new fragment using oligonucleotides 7 and 8 (Table
1). The PCR products of 3D WT and 3D D406N were cloned into pET26Ub using SacII and XhoI sites.
Construction of pET26Ub HRV-14 3C WT and 3C L94P.
Oligonucleotides 1 and 2 (Table
1) were used to amplify 3C WT. For 3C L94P, first two PCR fragments were amplified using oligonucleotides 1 and 4 and oligonucleotides 3 and 2 (Table
1) encoding point mutation L94P. These two fragments were then used as templates for the amplification of a new fragment using oligonucleotides 1 and 2 (Table
1). The PCR products of 3C WT and 3C L94P were cloned into pET26Ub-Chis plasmid using SacII and BamHI sites. pET26Ub-Chis is designed to produce a C-terminal GSSG-six-His tag for any protein coding sequence cloned in by using the 3′ BamHI1 site.
Construction of pET26Ub HRV-14 3CD and 3CD derivatives.
pET26Ub 3CD Chis was made the same way as described for pET26Ub 3C Chis. Three 3CD mutants, 3C*D (3C-L94P-D), 3CD* (3CD-D406N), and 3C*D* (3C-L94P-D-D406N), were made by PCR mutagenesis as described above. Oligonucleotides 1, 3, 4, and 8 were used for 3C*D; oligonucleotides 1 and 9 to 11 were used for 3CD*; and oligonucleotides 1, 3, 4, and 9 to 11 were used for 3C*D* PCR amplifications. All plasmids contain a mutation of cysteine 146 to a glycine to inactivate protease activity.
Construction of pET26Ub PV 3D D406N.
pET26Ub PV 3D-D406N was constructed as described previously for 3D WT (
8). Oligonucleotides 16 to 19 (Table
1) were used for the PCR amplifications. The PCR products were cloned into pET26Ub 3D WT using KpnI and EcoRI sites.
Expression and purification of HRV-14 3D polymerase.
Escherichia coli Rosetta pUbpS was transformed with pET26Ub HRV-14 3D WT or 3D D406N for protein expression. The strain Rosetta pUbpS carries the pUbpS plasmid, which constitutively expresses a yeast ubiquitin protease that processes the ubiquitin fusion protein to produce the authentic N terminus. Protein expression, precipitation of nucleic acid with polyethyleneimine, and ammonium sulfate precipitation were performed as previously described (
22). The ammonium sulfate pellet was resuspended in buffer A (50 mM Tris, pH 8.0, 0.1% Nonidet P-40, 20% glycerol, 10 mM β-mercaptoethanol) containing 150 mM NaCl and dialyzed against 1000 ml of dialysis buffer (buffer A with 150 mM NaCl) at 4°C overnight. After dialysis, the protein was adjusted to 50 mM NaCl and loaded at the speed of 1 ml/min onto a phosphocellulose (P-11) column equilibrated with buffer A containing 50 mM NaCl. Proteins were eluted with a gradient from 50 to 350 mM NaCl in buffer A. The eluted pooled fractions were loaded to a Q-Sepharose column as described for the P-11 column. The eluted fractions were adjusted with buffer A to 50 mM NaCl and loaded onto a 0.5-ml Q column, which was equilibrated with buffer A containing 50 mM NaCl. After loading, the column was washed with buffer B (50 mM HEPES, pH 7.5, 0.1% Nonidet P-40, 20% glycerol, 10 mM β-mercaptoethanol) containing 50 mM NaCl. Proteins were eluted with buffer B containing 500 mM NaCl and dialyzed against 1,000 ml of buffer B containing 50 mM NaCl at 4°C overnight. The protein concentration was determined at 280 nm in 6 M guanidine HCl, pH 6.5, using the extinction coefficient 0.0585 μM
−1·cm
−1.
Expression and purification of PV 3D polymerase.
Expression and purification of PV 3Dpol were performed as previously described (
8).
Expression and purification of HRV-14 3C WT and 3C L94P.
The BL21(DE3) pCG1 strain of
E. coli was transformed with pET26Ub HRV-14 3C six-His for protein expression. The protein expression, lysis, and polyethyleneimine and ammonium sulfate precipitation were performed as previously described (
22), except that 60% ammonium sulfate precipitation was employed. The ammonium sulfate pellet was resuspended in buffer A (50 mM Tris, pH 8.0, 0.1% Nonidet P-40, 20% glycerol, 10 mM β-mercaptoethanol) containing 500 mM NaCl and dialyzed against 1000 ml of dialysis buffer (buffer A with 500 mM NaCl) at 4°C overnight. After dialysis, the protein was adjusted to 500 mM NaCl and loaded onto a Ni-nitrilotriacetic acid-agarose column at the flow rate of 1 ml/min. The column was washed with 6× column volumes of buffer A containing 500 mM NaCl and 50 mM imidazole. Proteins were eluted with 2 M NaCl in buffer A containing 500 mM imidazole. The eluted pooled fractions were adjusted with buffer A to 50 mM NaCl and were purified using a phosphocellulose (P-11) column as described for HRV-14 3D purification. The protein concentration was determined at 280 nm in 6 M guanidine HCl, pH 6.5, using the extinction coefficient 0.0051 μM
−1·cm
−1.
Expression and purification of HRV-14 3CD WT and 3CD derivatives.
The BL21(DE3)pCG1 strain of
E. coli was transformed with pET26Ub HRV-14 3CD six-His for protein expression. The protein expression, lysis, and polethyleneimine and ammonium sulfate precipitation were performed as previously described (
22). The ammonium sulfate pellet was resuspended in lysis buffer (100 mM potassium phosphate, pH 8.0, 0.1% Nonidet P-40, 20% glycerol, 10 mM β-mercaptoethanol, 500 mM NaCl, 2.8 μg/ml pepstatin A, 2.0 μg/ml leupeptin, 2 mM phenylmethylsulfonyl fluoride). The protein was loaded onto a Ni-nitrilotriacetic acid-agarose column at the flow rate of 1 ml/min. The column was washed with buffer B (50 mM HEPES, pH 7.5, 0.1% Nonidet P-40, 20% glycerol, 10 mM β-mercaptoethanol) containing 500 mM NaCl and 20 mM imidazole. Proteins were eluted with 500 mM NaCl in buffer B containing 500 mM imidazole. The eluted pooled fractions were dialyzed against 1,000 ml of dialysis buffer (buffer B with 150 mM NaCl) at 4°C overnight. After dialysis, the protein was adjusted to 50 mM NaCl and loaded at the speed of 1 ml/min onto a phosphocellulose (P-11) column equilibrated with buffer B containing 50 mM NaCl and eluted with buffer B containing 500 mM NaCl. The eluted pooled fractions were dialyzed against buffer B containing 150 mM NaCl at 4°C overnight. The protein concentration was determined at 280 nm in 6 M guanidine HCl, pH 6.5, using the extinction coefficient 0.0636 μM
−1·cm
−1.
Subgenomic replicon assays.
Subgenomic HRV-14 replicons were constructed as described previously (
32). RNAs transcribed in vitro from these constructs were transfected into HeLa cells, which were seeded into six-well plates, and cultured in Dulbecco modified Eagle medium with 10% fetal bovine serum at 34°C. Cell lysates were harvested by the addition of 125 ml of passive lysis buffer (Promega) to each well and stored at −70°C until assayed for enzymatic activity. Luciferase activity was quantified using the Luciferase Assay System as described by the supplier (Promega), and the results were determined using a TD-20/20 luminometer (Turner Designs).
VPg uridylylation assays.
The reaction mixture contained 1 μM 3C or 3CD, 1 μM HRV-14 97-nt oriI or PV 61-nt oriI, and 10 μM VPg in reaction buffer (50 mM HEPES, pH 7.5, 5 mM magnesium acetate, 10% glycerol, 10 mM β-mercaptoethanol, 0.04 μM [α-32P]UTP [6,000 Ci/mmol], and 10 μM unlabeled UTP). The reaction mixture was preheated at 30°C for 5 min. Reactions were initiated with 3D (10 μM for HRV-14 or 1 μM for PV). All enzymes were diluted immediately prior to use in enzyme dilution buffer (50 mM HEPES, pH 7.5, 10 mM β-mercaptoethanol, 20% glycerol). After incubation at 30°C for 30 min, the reaction was then stopped by the addition of an equal volume (5 μl) of gel loading buffer (100 mM EDTA in 75% formamide, 0.025% bromophenol blue, and 0.025% xylene cyanol). The quenched samples (5 μl) were analyzed by Tris-Tricine sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. The incorporation of [α-32P]UMP was measured on a PhosphorImager and quantified by using ImageQuant software. The concentration of VPg extended was calculated using values for the counts associated with the indicated components in the equation [(VPg-pU + VPg-pUpU/2)/(VPg-pU + VPg-pUpU/2 + UTP)] × [UTP]. The processivity of the reaction is defined as follows: [VPg-pUpU]/[VPg-pUpU] + [VPg-pU].
RNA filter binding assays.
For direct binding experiments, the reaction mixture (20 μl) contained 10 nM trace-labeled HRV-14 97-nt oriI or PV-1 61-nt oriI and various concentrations of WT HRV-14 3C. For competitive binding experiments, the reaction mixture (20 μl) contained 10 nM trace-labeled HRV-14 97-nt oriI and various concentrations of unlabeled PV 61-nt oriI or unlabeled HRV-14 97-nt oriI. In all cases, the reaction buffer contained 50 mM HEPES (pH 7.5), 20 mM NaCl, 5 mM magnesium acetate, 20% glycerol, and 10 mM β-mercaptoethanol. The binding reactions were initiated with 0.03 μM 3C, and the reaction mixtures were incubated at 30°C for 15 s (direct binding) or 15 min (competitive binding). 3C was diluted immediately prior to use in enzyme dilution buffer as described above. Three filters were employed, and the filter binding assays were performed as previously described (
22).
Poly(rU) polymerase activity.
The reaction mixture (25 μl) contained 0.5 μM 3Dpol, 2 μM dT15, 0.2 μM poly(rA)467, 500 μM UTP, and 0.4 μCi/μl [α-32P]UTP in enzyme buffer (50 mM HEPES, pH 7.5, 5 mM NaCl, 5 mM MgCl2, 20% glycerol, and 10 mM β-mercaptoethanol). Experiments were performed at 30°C and initiated with 3Dpol. After 5 min of incubation, the reactions were quenched by addition of EDTA to a final concentration of 50 mM. Five microliters of quenched reaction was spotted onto Whatman DE-81 filter paper. Dried filter paper was washed three times with 5% (wt/vol) dibasic sodium phosphate. Bound radioactivity was quantified by liquid scintillation counting.
Rapid chemical quench flow experiments.
Experiments were performed at 30°C by using a circulating water bath and using a model RQF-3 chemical quench flow apparatus (KinTek Corp., State College, PA) (
3,
4). 3Dpol and sym/sub were mixed for 3 min at room temperature, and then the 3Dpol-sym/sub complexes were rapidly mixed with the nucleotide substrate. The reactions were quenched by adding EDTA to a final concentration of 0.3 M.
DISCUSSION
oriI-dependent VPg uridylylation is essential for production of progeny picornaviral genomes (
23). oriI is often described as a bipartite element containing a loop that has sequence (
23) and perhaps structural (
23) signatures essential for templating VPg uridylylation and a stem that serves only a structural role (
23). Numerous observations are consistent with this model. Replication of picornaviruses appears to be much more sensitive to substitutions in the loop than in the stem. Indeed, completely artificial stems have been shown to function for PV-3 (
10). PV-1 replication is supported by heterologous oriI elements, for example, that from HRV-14 (
25). Therefore, it was quite surprising that PV-3 oriI did not support HRV-14 replication (
32). This observation was not related to sequence differences between PV-3 and PV-1 oriI elements (Fig.
2A), as PV-1 oriI did not support HRV-14 replication (Fig.
2C). Interestingly, the inability of HRV-14 to use PV-3 oriI was determined by the stem. An HRV-14/PV-3 chimera containing the PV-3 loop and HRV-14 stem replicated well, suggesting that the stem sequence is an important determinant for oriI function (
32). HRV-14 could adapt to use PV-3 oriI by acquiring mutations that changed 3C (L94P) or 3D (D406N) (
32). These same changes permitted HRV-14 to use PV-1 oriI (Fig.
2C). The motivation for this study was elucidation of the mechanistic basis for the adaptive changes in HRV-14 3C and 3D with the hope of gaining a better understanding of the structure, function, and mechanism of the PV VPg uridylylation complex.
We established an in vitro VPg uridylylation system for HRV-14 (Fig.
3) that recapitulates the observations made biologically (Fig.
4). The 3D mutation functions at the level of 3Dpol (Fig.
4A). The 3C mutation functions at the level of 3C(D) (Fig.
4B). The two mutations were additive (Fig.
4C), suggesting that each change conferred an independent, new function on the VPg uridylylation complex.
Although the factor and element requirements for VPg uridylylation are well established, the mechanisms for assembly and stability, stoichiometry, and organization of the VPg uridylylation complex have only recently begun to be defined (Fig.
1) (
21). Pathak et al. (
21) have suggested that a dimer of 3C(D) binds to oriI followed by isomerization of this complex such that the upper stem is unwound. Binding to the upper stem is directed by 3C. The isomerized complex would be stabilized by interaction of 3C molecules with single strands of the upper stem, extending the loop into a conformation more easily bound by 3Dpol. Stable association of 3Dpol with this complex would be mediated by an interaction between the back of the thumb of 3Dpol and surfaces of the 3C dimer. As discussed below, our biochemical analysis of the HRV-14 3C and 3Dpol derivatives that permit use of PV-1 oriI (Fig.
5 to
8) provides additional support for this model.
Although 3C did not exhibit a preference for HRV-14 oriI relative to PV-1 oriI in direct binding experiments (Fig.
7B), 3C exhibited a higher affinity for HRV-14 oriI than PV-1 oriI in competition experiments (compare panel i of Fig.
6A and B to panel i of Fig.
6C and D and Fig.
7C and D). This higher affinity was due to the upper stem, as a PV-1/HRV-14 oriI chimera containing the HRV-14 stem bound to 3C better than a chimera containing the HRV-14 loop (Fig.
8). We conclude that 3C binds to the upper stem of oriI in a sequence-independent fashion that may be structure sensitive. This complex isomerizes into a form that is stabilized by sequence-specific interactions with the upper stem of oriI. A sequence-specific interaction between 3C and the stem would likely require opening after 3C binding, consistent with a two-step binding mechanism (
21). Although the bases of double-stranded DNA are accessible from the major groove (
20), the bases of double-stranded RNA are much less accessible to protein (
5). We propose that HRV-14 3C exhibits greater sequence specificity than PV 3C. The more stringent selection imposed by HRV-14 may be a reflection of the weak binding to oriI suggested by titration experiments: we found a
K0.5 value of 20 μM for HRV-14 oriI (panel i of Fig.
6A) and a
K0.5 value of 100 μM for PV-1 oriI (panel i of Fig.
6C). Comparable experiments with PV-1 3C showed a
K0.5 value of 2 μM for PV-1 oriI (
21). If the higher affinity of PV-1 3C for oriI RNAs extrapolates to a broader specificity, then PV-1 would be expected to be less stringent in its selection of oriI elements for replication as reported previously (
21).
HRV-14 3C-L94P exhibited a higher affinity than WT 3C for both HRV-14 oriI (
K0.5 of 10 μM) and PV-1 oriI (
K0.5 of 20 μM) (panel i of Fig.
6A and C), consistent with the enhanced capacity of the HRV-14 3C-L94P replicon to replicate by using PV-3 (
32) or PV-1 oriI (Fig.
2C). HRV-14 3C-L94P still exhibited a preference for binding HRV-14 oriI (Fig.
8). Leu-94 is not conserved across all PV 3C proteins; however, this region of 3C protein has been shown previously to be involved in RNA binding (
19). Nayak et al. have shown that residues 92, 95, and 97 of foot-and-mouth disease virus 3C protein are required for foot-and-mouth disease virus oriI binding, VPg uridylylation in vitro, and genome replication in tissue culture (
19). We have also identified this region as a determinant for PV-1 oriI binding by PV-1 3C by using nuclear magnetic resonance spectroscopy (unpublished observations). We conclude that after formation of the initial 3C
2-oriI complex, the duplex opens and each 3C molecule interacts with single-stranded RNA in a sequence-dependent fashion by using residues in the vicinity of residue 94. The adaptive change in 3C not only increases the affinity of this 3C derivative for RNA in general but also expands the sequence specificity of the protein, resulting in the formation of more stable VPg uridylylation complexes. This two-step, sequence-specific binding mechanism observed for 3C binding to oriI may also be required for 3C binding to
cis-acting replication elements at the 5′ and 3′ ends of picornaviral genomes.
HRV-14 3Dpol-D406N supported increased VPg uridylylation by using either HRV-14 oriI or PV-1 oriI. This substitution also increased the VPg uridylylation activity of PV-1 3Dpol (Table
2). 3Dpol-D406N was not more active than WT 3Dpol, as RNA-primed elongation activity was unchanged (data not shown; also Table
2). HRV-14 3Dpol-D406N assembled more readily into the HRV-14 3C
2-oriI complex, as the
K0.5 value for oriI was reduced by eightfold relative to that of WT 3Dpol to 2 μM (panel i of Fig.
5A). A fivefold reduction in K
0.5 value to 20 μM was observed when PV-1 oriI was employed (compare panel i of Fig.
6C to panel i of Fig.
6D). HRV-14 3Dpol-D406N was also retained more efficiently in the VPg uridylylation complex because increased processivity was observed relative to WT 3Dpol when VPg (panel ii of Fig.
5C) or PV-1 oriI (panel ii of Fig.
6D) was titrated. Because Asp-406 is located at the top of the thumb of 3Dpol and the back of the thumb has been clearly implicated in an interaction with the 3C dimer for assembly of the VPg uridylylation complex (Fig.
1) (
21), we conclude that 3Dpol-D406N assembles more efficiently and more stably with the 3C dimer, leading to increased production of more processive VPg uridylylation complexes.
Assembly of stable VPg uridylylation complexes is essential for picornavirus genome replication. This study suggests that the kinetics of assembly and overall stability of the HRV-14 VPg uridylylation complex exist at the optimal value, leading to a rate of VPg uridylylation that prevents this step in viral RNA synthesis from being rate limiting in infected cells. Substitution of PV oriI into the HRV-14 genome reduces replication, most likely due to a reduced level of VPg-pUpU production (Fig.
3). Although both gain-of-function mutants supported five- to eightfold-increased production of VPg-pUpU (Fig.
4A and B), neither mutant altered the kinetics of HRV-14 genome replication in tissue culture (
32). The finding that PV-1 could use HRV-14 oriI without any significant impact on the kinetics of genome replication may suggest that the kinetics of assembly and/or overall stability of the PV-1 VPg uridylylation complex greatly exceed the optimal value. If this is the case, then PV-1 may be more tolerant to changes or disruptions in VPg uridylylation components. For example, it has been suggested that oriI-templated production of VPg-pUpU is not required for PV-1 negative-strand RNA synthesis based on the observation that mutations in PV-1 oriI that severely impair VPg uridylylation have no impact on negative-strand RNA synthesis in a cell-free system (
17,
18). If PV-1 produces far more VPg-pUpU than needed, then even a substantial reduction in the concentration of VPg-pUpU may be tolerated. Therefore, it remains possible that oriI is used for negative-strand RNA synthesis (
16). Given the sensitivity of HRV-14 to changes in oriI, this system may be useful in clarifying this issue.